Log in

ORNAV Orion Oyj OMXHEX · Finland

Orion Oyj (ORNAV) news

Orion Oyj is a public biotech or pharmaceutical company listed on OMXHEX under the ticker ORNAV, recorded under Finland. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Orion Oyj news

We have not published a story on Orion Oyj yet. When there is news, it will appear here.

Questions about Orion Oyj

What is the ticker symbol of Orion Oyj?

Orion Oyj trades under the ticker ORNAV on OMXHEX.

Where is Orion Oyj listed?

Orion Oyj is listed on OMXHEX. Our directory also records these other listings: EUROTLX:4ORNBV; GETTEX:OFK; LS:A0J3QM; LSE:0M2N; LSIN:0M2O; LSX:A0J3QL; LSX:A0J3QM; OMXHEX:ORNBV; OTC:ORINY.

Which country or territory is Orion Oyj listed under?

Our directory records Orion Oyj under Finland.

What does Orion Oyj do?

Our directory classifies Orion Oyj as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Orion Oyj?

The ISIN recorded for Orion Oyj is FI0009014369.

Does aibio.space cover Orion Oyj?

aibio.space lists Orion Oyj among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Orion Oyj?

Companies in our directory listed in the same country and business area as Orion Oyj: Faron Pharmaceuticals Oy, Herantis Pharma Plc, Nanoform Finland Oyj.

Investor discussion: Orion Oyj

Members talk about Orion Oyj (ORNAV). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OMXHEX:ORNAV on TradingView.

Listing details

Orion Oyj is a public biotech or pharmaceutical company listed on OMXHEX under the ticker ORNAV, recorded under Finland. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Orion Oyj
Ticker
ORNAV
Listing
OMXHEX
Country or territory
Finland
Business scope
Pharmaceuticals: Major
ISIN
FI0009014369
Other listed symbols
EUROTLX:4ORNBV; GETTEX:OFK; LS:A0J3QM; LSE:0M2N; LSIN:0M2O; LSX:A0J3QL; LSX:A0J3QM; OMXHEX:ORNBV; OTC:ORINY
Last quote in directory
2026-10-21
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.